From: In silico pathway analysis based on chromosomal instability in breast cancer patients
Chromosomal region | Genesa |
---|---|
1p32 | RNF11 |
1q21 | ARNT, SHC1, PIP5K1A, S100A10, BCL9, MAD1L1, PDE4DIP |
2p21 | EML4 |
2p22 | NLRC4, MSN, BIRC6, STRN, EIF2AK2 |
2p23 | NCOA1, ALK |
3p21 | LIMD1, MAP4, RHOA, PFKFB4, MST1, SEMA3F, SETD2, PBRM1, BAP1, PBRM1, PRKCD |
3q25 | WWTR1, SIAH2, MLF1, RARRES1 |
4q12 | FIP1L1 |
4q31 | INPP4B, NR3C2 |
5q31 | AFF4, SLIT3, VDAC1, ANKHD1, HDAC3, ARHGAP26 |
6q13 | SMAP1 |
6q25 | RGS17, AKAP12, LATS1 |
6q27 | FGFR10P, THBS2 |
7q22 | CUX1 |
10q21 | CCDC6, RHOBTB1, ARID5B |
11q23 | SDHD, ARHGEF12 |
15q22 | PCLAF, DAPK2 |
17q21 | GSDMB, RARA, CDC6, STAT3, GAST, ACLY, BRCA1, ETV4, NMT1, KPNB1, IGF2BP1, NGFR, XYLT2, PPP1R9B, COL1A1 |